N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide

C24H30N8OS — CID 10028055

IUPACN-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide
SMILESCC(C)N1CCN(c2cc(Nc3ccn[nH]3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)CC1
InChIInChI=1S/C24H30N8OS/c1-16(2)31-11-13-32(14-12-31)22-15-21(27-20-9-10-25-30-20)28-24(29-22)34-19-7-5-18(6-8-19)26-23(33)17-3-4-17/h5-10,15-17H,3-4,11-14H2,1-2H3,(H,26,33)(H2,25,27,28,29,30)
InChIKeyNBEFVBASBOPXBS-UHFFFAOYSA-N
MW478.63 g/mol
LogP3.97
Rot. Bonds8

About N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide

N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide (PubChem CID 10028055) has the molecular formula C24H30N8OS and a molecular weight of 478.63 g/mol. Its IUPAC name is N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide.

Molecular Properties

Compound NameN-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide
PubChem CID10028055
Molecular FormulaC24H30N8OS
Molecular Weight478.63 g/mol
Exact Mass478.23
IUPAC NameN-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide
SMILESCC(C)N1CCN(c2cc(Nc3ccn[nH]3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)CC1
InChIInChI=1S/C24H30N8OS/c1-16(2)31-11-13-32(14-12-31)22-15-21(27-20-9-10-25-30-20)28-24(29-22)34-19-7-5-18(6-8-19)26-23(33)17-3-4-17/h5-10,15-17H,3-4,11-14H2,1-2H3,(H,26,33)(H2,25,27,28,29,30)
InChIKeyNBEFVBASBOPXBS-UHFFFAOYSA-N
XLogP3.97
TPSA102.07 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms34
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500478.63
LogP ≤ 53.97
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide?
The IUPAC name of N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide (CID 10028055) is N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide.
What is the SMILES notation for N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide?
The canonical SMILES for N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide is CC(C)N1CCN(c2cc(Nc3ccn[nH]3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)CC1.
What is the InChIKey of N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide?
The InChIKey is NBEFVBASBOPXBS-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H30N8OS/c1-16(2)31-11-13-32(14-12-31)22-15-21(27-20-9-10-25-30-20)28-24(29-22)34-19-7-5-18(6-8-19)26-23(33)17-3-4-17/h5-10,15-17H,3-4,11-14H2,1-2H3,(H,26,33)(H2,25,27,28,29,30).
What are the key properties of N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide?
N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide has a molecular weight of 478.63 g/mol, XLogP of 3.97, 8 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[4-(4-propan-2-ylpiperazin-1-yl)-6-(1H-pyrazol-5-ylamino)pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide is sourced from PubChem (CID 10028055), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).